Josee-Lyne Ethier
机构: Medical Oncologist/Associate Professor, Queen's University
每年引用次数
引用次数
引用: 1,611
H-指数: 14
I10-指数 : 18
出版物: 46
Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis.
R. Barua , A.J. Templeton , B. Seruga , A. Ocana
Clinical Oncology 30 ( 4) 215 -224
12
2018
A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: Are recommendations sensitive to different global resources?
S. Gandhi , S. Verma , J.-L. Ethier , C. Simmons
The Breast 24 ( 4) 309 -317
6
2015
Abstract P4-14-03: Influence of competing risks of death on the interpretation of adjuvant endocrine therapy trials for breast cancer
J-L Ethier , W Parulekar , L Shepherd , L Summers
Cancer Research 79
2
2019
Abstract P5-14-05: Capecitabine in early breast cancer: A meta-analysis of randomized controlled trials
A Natori , J-L Ethier , E Amir , DW Cescon
Cancer Research 77
2017
Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review.
Laurie Elit , Hal Hirte , Josee-Lyne Ethier , Lauri Petz
Critical Reviews in Oncology Hematology 162 103324 -103324
2021
Influence of the competing risk of death on estimates of disease recurrence in trials of adjuvant endocrine therapy for early-stage breast cancer: A secondary analysis of MA.27, MA.17 and MA.17R.
Josee-Lyne Ethier , Geoffrey M Anderson , Peter C Austin , Mark Clemons
European Journal of Cancer 149 117 -127
2021
P53 functional mutation type in high-grade serous ovarian cancer and clinical outcomes.
Victoria Mandilaras , Swati Garg , Julia Burnier , Katherine Karakasis
Journal of Clinical Oncology 34 5550 -5550
2016
Outcomes of single versus double hormone receptor positive breast cancer.
Josee-Lyne Ethier , Alberto Ocana , Maribel Casas , Maria Sanchez-Arago
Journal of Clinical Oncology 34 569 -569
2016
Survival outcomes in patients with platinum-resistant (PL-R) ovarian cancer (OC): The Princess Margaret Cancer Centre (PM) experience.
Josee-Lyne Ethier , Lisa Wang , Amit M. Oza , Stephanie Lheureux
Journal of Clinical Oncology 35
2017
Clinical trial of biopsies in oncology: Patient-reported impact (BIOPSY).
Michelle K Wilson , Stephanie Lheureux , Sunu Cyriac , Neesha C Dhani
Journal of Clinical Oncology 35
2017
Hyperglycemia and survival in solid tumors: A systematic review and meta-analysis.
Reeta Barua , Arnoud J Templeton , Bostjan Seruga , Alberto Ocana
Journal of Clinical Oncology 35
2017
The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.
Josee-Lyne Ethier , Eitan Amir ,
Molecular Diagnosis & Therapy 20 ( 4) 307 -313
3
2016
Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses
Alberto Ocana , Josee-Lyne Ethier , Laura Díez-González , Verónica Corrales-Sánchez
Oncotarget 6 ( 37) 39538 -39549
16
2015
Prognostic Role of Neutrophil-To-Lymphocyte Ratio in Breast Cancer: A Systematic Review and Meta-Analysis
Josee-Lyne Ethier , Danielle Desautels , Arnoud Templeton , Prakesh S Shah
Breast Cancer Research 19 ( 1) 2 -2
197
2017
Barriers to goals of care discussions with patients with advanced cancer and their families: A multicenter survey of oncologists.
Josee-Lyne Ethier , Thivaher Paramsothy , Sonal Gandhi
Journal of Clinical Oncology 33 15 -15
6
2015
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
Josee-Lyne Ethier , Danielle N Desautels , Arnoud J Templeton , Amit Oza
Gynecologic Oncology 145 ( 3) 584 -594
46
2017
Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis
Josee-Lyne Ethier , Danielle N Desautels , Eitan Amir , Helen MacKay
Gynecologic Oncology 147 ( 1) 158 -166
24
2017
Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials
Akina Natori , Josee-Lyne Ethier , Eitan Amir , David W Cescon
European Journal of Cancer 77 40 -47
30
2017
Immunologic and genomic characterization of high grade serous ovarian cancer (HGSOC) in patients (pts) treated with pembrolizumab (Pembro) in the phase II INSPIRE trial.
Ilaria Colombo , Scott Lien , Cindy Yang , Derek L Clouthier
Journal of Clinical Oncology 35 5581 -5581
1
2017
Author Financial Conflicts of Interest, Industry Funding, and Clinical Practice Guidelines for Anticancer Drugs
Ariadna Tibau , Philippe L Bedard , Amirrtha Srikanthan , Josee-Lyne Ethier
Journal of Clinical Oncology 33 ( 1) 100 -106
28
2015